851 related articles for article (PubMed ID: 21544079)
1. Case definition and phenotype standardization in drug-induced liver injury.
Aithal GP; Watkins PB; Andrade RJ; Larrey D; Molokhia M; Takikawa H; Hunt CM; Wilke RA; Avigan M; Kaplowitz N; Bjornsson E; Daly AK
Clin Pharmacol Ther; 2011 Jun; 89(6):806-15. PubMed ID: 21544079
[TBL] [Abstract][Full Text] [Related]
2. Enhancing the utility of alanine aminotransferase as a reference standard biomarker for drug-induced liver injury.
Ozer JS; Chetty R; Kenna G; Palandra J; Zhang Y; Lanevschi A; Koppiker N; Souberbielle BE; Ramaiah SK
Regul Toxicol Pharmacol; 2010 Apr; 56(3):237-46. PubMed ID: 19903504
[TBL] [Abstract][Full Text] [Related]
3. Idiosyncratic drug-induced liver injury: an update on the 2007 overview.
Hussaini SH; Farrington EA
Expert Opin Drug Saf; 2014 Jan; 13(1):67-81. PubMed ID: 24073714
[TBL] [Abstract][Full Text] [Related]
4. Predicting and preventing acute drug-induced liver injury: what's new in 2010?
Liss G; Rattan S; Lewis JH
Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1047-61. PubMed ID: 20615079
[TBL] [Abstract][Full Text] [Related]
5. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.
Teschke R
Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1169-1187. PubMed ID: 30354694
[TBL] [Abstract][Full Text] [Related]
6. Liver safety assessment: required data elements and best practices for data collection and standardization in clinical trials.
Avigan MI; Bjornsson ES; Pasanen M; Cooper C; Andrade RJ; Watkins PB; Lewis JH; Merz M
Drug Saf; 2014 Nov; 37 Suppl 1(Suppl 1):S19-31. PubMed ID: 25352325
[TBL] [Abstract][Full Text] [Related]
7. Causality assessment in drug-induced liver injury.
Hayashi PH
Semin Liver Dis; 2009 Nov; 29(4):348-56. PubMed ID: 19826968
[TBL] [Abstract][Full Text] [Related]
8. Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop.
Fontana RJ; Seeff LB; Andrade RJ; Björnsson E; Day CP; Serrano J; Hoofnagle JH
Hepatology; 2010 Aug; 52(2):730-42. PubMed ID: 20564754
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced liver injury and drug development: industry perspective.
Regev A
Semin Liver Dis; 2014 May; 34(2):227-39. PubMed ID: 24879986
[TBL] [Abstract][Full Text] [Related]
10. Causality assessment for suspected DILI during clinical phases of drug development.
Regev A; Seeff LB; Merz M; Ormarsdottir S; Aithal GP; Gallivan J; Watkins PB
Drug Saf; 2014 Nov; 37 Suppl 1(Suppl 1):S47-56. PubMed ID: 25352327
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced liver injury: what was new in 2008?
Liss G; Lewis JH
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):843-60. PubMed ID: 19505188
[TBL] [Abstract][Full Text] [Related]
12. Liver enzyme abnormalities during concurrent use of herbal and conventional medicines in Korea: a retrospective study.
Kim NH; Jung HY; Cho SY; Park SU; Park JM; Ko CN
Phytomedicine; 2011 Nov; 18(14):1208-13. PubMed ID: 21802919
[TBL] [Abstract][Full Text] [Related]
13. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an international consensus meeting.
Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):317-22. PubMed ID: 2272712
[TBL] [Abstract][Full Text] [Related]
14. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis.
Weber S; Benesic A; Rotter I; Gerbes AL
Liver Int; 2019 Oct; 39(10):1906-1917. PubMed ID: 31319011
[TBL] [Abstract][Full Text] [Related]
15. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct.
Fontana RJ; Watkins PB; Bonkovsky HL; Chalasani N; Davern T; Serrano J; Rochon J;
Drug Saf; 2009; 32(1):55-68. PubMed ID: 19132805
[TBL] [Abstract][Full Text] [Related]
16. The phenotype standardization project: improving pharmacogenetic studies of serious adverse drug reactions.
Pirmohamed M; Aithal GP; Behr E; Daly A; Roden D
Clin Pharmacol Ther; 2011 Jun; 89(6):784-5. PubMed ID: 21593754
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced liver injury.
Leise MD; Poterucha JJ; Talwalkar JA
Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
[TBL] [Abstract][Full Text] [Related]
18. Relapse and Need for Extended Immunosuppression: Novel Features of Drug-Induced Autoimmune Hepatitis.
Weber S; Gerbes AL
Digestion; 2023; 104(3):243-248. PubMed ID: 36603570
[TBL] [Abstract][Full Text] [Related]
19. Review article: Drug-induced liver injury--its pathophysiology and evolving diagnostic tools.
Au JS; Navarro VJ; Rossi S
Aliment Pharmacol Ther; 2011 Jul; 34(1):11-20. PubMed ID: 21539586
[TBL] [Abstract][Full Text] [Related]
20. Chronic liver injury induced by drugs and toxins.
Ortega-Alonso A; Andrade RJ
J Dig Dis; 2018 Sep; 19(9):514-521. PubMed ID: 29808546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]